Results 21 to 30 of about 137,477 (311)

The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness

open access: yesMedicina, 2023
Background and Objectives: Papillary thyroid carcinoma (PTC) is one of the most common malignancies of the endocrine system. In order to improve the ability to predict tumor behavior, several studies have been conducted to search for surrogate prognostic
Mohammad Sheikh-Ahmad   +10 more
doaj   +1 more source

A Metastatic Papillary Thyroid Carcinoma Could be Confused Clinically with a Primary Renal Neoplasm; A Case Report and Literature Review

open access: yesAsian Pacific Journal of Cancer Biology, 2022
Background: Papillary thyroid carcinoma is the most common thyroid neoplasm. It has a very high incidence of regional lymph node metastasis at the initial presentation. However, vascular spread is a very uncommon event.
Noha ED Hassab El-Naby   +1 more
doaj   +1 more source

Retinoblastoma Expression in Thyroid Neoplasms [PDF]

open access: yesModern Pathology, 2000
Retinoblastoma (Rb) mutation in thyroid neoplasia has been identified in a few molecular studies; however, the utility of Rb immunohistochemistry in distinguishing benign and malignant thyroid lesions has not been documented in formalin-fixed, paraffin-embedded tissues.
F, Anwar   +4 more
openaire   +2 more sources

Follicular thyroid carcinoma metastatic to skin: a small papule and a big diagnostic change [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2019
: Cutaneous metastases are uncommon in daily practice, although very important, since they may be the first manifestation of an undiscovered primary neoplasm or the first indication of recurrence.
Marcia Lanzoni Alvarenga Lira   +3 more
doaj   +2 more sources

Struma ovarii with follicular thyroid-type carcinoma and neuroendocrine component: case report

open access: yesWorld Journal of Surgical Oncology, 2012
Struma ovarii (SO) is a slow-growing ovarian neoplasm with thyroid tissue as its predominant component. It is an uncommon neoplasm, usually asymptomatic with an unknown risk of malignant transformation.
Selvaggi Federico   +7 more
doaj   +1 more source

Horner’s Syndrome and Thyroid Neoplasms

open access: yesORL, 2002
Although thyroid goiter is a common condition, it rarely results in Horner’s syndrome. We report a case of a patient with an intrathoracic multinodular goiter complicated by Horner’s syndrome. Benign thyroid disease was confirmed pathologically, and the patient’s symptoms improved after surgery.
Leuchter, Igor   +3 more
openaire   +4 more sources

Unusual Presentation of Differentiated Thyroid Cancer Metastasis

open access: yesInternational Archives of Otorhinolaryngology, 2018
Introduction The rates of thyroid cancers are on a rise, especially well-differentiated thyroid cancers. This could be partly due to newer diagnostic modalities, like high-resolution ultrasound, that can pick up smaller lesions.
Haissan Iftikhar   +3 more
doaj   +1 more source

Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:The follicular variant of papillary thyroid cancer (FVPTC), especially the encapsulated non-invasive subtype, is a controversial entity.
Min Ji Jeon   +14 more
doaj   +1 more source

Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting

open access: yesInternational Journal of Endocrinology, 2017
Background. Fine needle aspiration (FNA) remains the first-line diagnostic in management of thyroid nodules and reduces unnecessary surgeries. However, it is still challenging since cytological results are not always straightforward.
Aili Guo   +4 more
doaj   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy